| Nazwa produktu: |
4-(3,4-Dichlorophenyl)-1-tetralone |
| Angielska nazwa |
4-(3,4-Dichlorophenyl)-1-tetralone; 4-(3,4-Dichlorophenyl)-3,4-dihydronaphthalene-1(2H)-one; 4-(3,4-Dichlorophenyl)-1-naphthalenone; 4-(3,4-Dichlorophenyl)-3,4-DIHYDRONAPHTHALEN-1-(2H)-ONE; 4-(3',4'-Dichlorophenyl)-1-TETRALONE; 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalene-1-one; 4-(3,4-dichlorophenyl)-3,4-dihydro-1-(2h)-naphthalenone; 4-(3,4-dichlophenyl)-3,4-dihydro-1-(2H)-naphthalenone; 1(2H)-Naphthalenone,4-(3,4-dichlorophenyl)-3,4-dihydro-; 4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenone; 4-(3,4-Dichlorophenyl)-1-oxo-1,2,3,4-tetrahydronaphthalene; 4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone; 4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalone; 4-(3,4-dichloro-phenyl)-1-tetralone; CP 52608; Sertralinetetralone; Sertralone |
| MF |
C16H12Cl2O |
| Masie cząsteczkowej |
291.18 |
| Nr CAS |
79560-19-3;79836-44-5 |
| Struktury molekularnej |
|
| Symbole zagrożenia |
 Xi:;
|
| Kody ryzyka |
|
| Bezpieczeństwo opis |
|
|
